A detailed history of Ss&H Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ss&H Financial Advisors, Inc. holds 959 shares of LLY stock, worth $762,740. This represents 0.31% of its overall portfolio holdings.

Number of Shares
959
Previous 837 14.58%
Holding current value
$762,740
Previous $757,000 12.29%
% of portfolio
0.31%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $94,201 - $117,122
122 Added 14.58%
959 $850,000
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $4,781 - $6,592
11 Added 1.33%
837 $450,000
Q2 2022

Jul 14, 2022

SELL
$278.73 - $327.27 $69,682 - $81,817
-250 Reduced 23.23%
826 $268,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $252,526 - $313,826
1,076 New
1,076 $308,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ss&H Financial Advisors, Inc. Portfolio

Follow Ss&H Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ss&H Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ss&H Financial Advisors, Inc. with notifications on news.